A new generation of infectious
disease immunotherapies and vaccines

Inovio’s novel DNA immunotherapy technology has created the potential for a new generation of infectious disease treatments and preventive vaccines. We are able to design immunotherapies/vaccines targeting multiple antigens of a disease, with techniques designed to protect against the inevitable mutations that occur.

We have developed SynCon® vaccines to not only prevent but treat a variety of infectious diseases. Our most advanced programs are in hepatitis, HIV, Ebola, and influenza, which are in clinical studies. Many of these programs are being conducted and/or funded in collaboration with respected research organizations.